Cold Wallet Presale Surpasses Near Protocol and Bitterson in Market Momentum

Generated by AI AgentCoin World
Tuesday, Aug 12, 2025 11:11 pm ET1min read
Aime RobotAime Summary

- Cold Wallet's Stage 17 presale surpasses Near Protocol and Bitterson in market momentum, raising $5.89M at $0.00998 per CWT token.

- The project's cashback model offers 100% gas fee refunds in CWT, creating a self-sustaining ecosystem with tiered rewards for blockchain activity.

- Integration with Plus Wallet's 2M users and CoinMarketCap listing enhances credibility, positioning it as a top presale opportunity with projected 3,425% ROI.

- While Near Protocol (+4.2% 24h) and Bitterson's TAO show long-term potential, Cold Wallet's immediate utility-driven growth model attracts analysts' attention.

Cold Wallet’s Stage 17 presale has attracted significant attention, outpacing both Near Protocol and Bitterson in terms of current market momentum [1]. The project is currently selling its utility token, CWT, at $0.00998 in Stage 17, with early investors having already raised $5.89 million [1]. The projected launch price is $0.3517, which suggests a potential 3,425% return on investment [1]. So far, 706.24 coins have been sold, indicating strong initial demand.

What differentiates Cold Wallet from other projects is its cashback-based model and tiered reward system. Users earn CWT for paying gas fees, making swaps, or transferring funds on or off the blockchain, creating a self-sustaining ecosystem where active participation is directly rewarded [1]. The integration with Plus Wallet’s 2 million users further amplifies its growth potential, offering a unique value proposition by rewarding users instead of draining their funds [1]. Additionally, a verified listing on CoinMarketCap enhances the project’s legitimacy and visibility.

Cold Wallet’s top-tier cashback model offers a 100% gas fee refund in CWT, which analysts believe incentivizes long-term holding and continuous usage [1]. This mechanism fosters a cycle of increased network activity and loyalty, making it an attractive option for investors seeking both utility and growth. The project’s low entry price and strong fundamentals have positioned it as one of the most promising presale opportunities at the moment [1].

Meanwhile, Near Protocol has seen a 4.2% increase in price within 24 hours, rising from $2.43 to $2.53 [1]. Analysts attribute this growth to institutional interest and ecosystem expansion, including progress from Aurora Labs and Subzero Labs securing $20 million in funding [1]. The increase is considered more structural than speculative, supported by on-chain activity and developer engagement, suggesting long-term relevance.

Bitterson’s TAO token is also drawing attention, with analysts forecasting strong performance. Some projections suggest an average price of $625.96 in 2025, with a high of $1,108.53 [1]. Looking ahead, 2031 forecasts are even more bullish, with expected price ranges between $2,491 and $2,698 [1]. These projections are based on network growth, use case expansion, and ongoing development, though they remain speculative and not guaranteed.

While both Near Protocol and Bitterson offer compelling long-term prospects, Cold Wallet is currently capturing more immediate interest. Its model rewards real-world usage, ensuring that value is generated and returned to the community through daily blockchain activity [1]. This structural advantage, combined with a low entry price and growing adoption, has led analysts to highlight Cold Wallet as one of the best crypto coins to buy before its official launch.

[1] Source: Cold Wallet Stage 17 Presale Beats Near Protocol & Bitterson — [https://coinmarketcap.com/community/articles/689c00ce5471a54f40af8566/](https://coinmarketcap.com/community/articles/689c00ce5471a54f40af8566/)

Quickly understand the history and background of various well-known coins

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet